Danaher shares jump 7% as the turnaround in biotech spending finally arrives

Earnings

In this photo illustration, a Danaher Corporation logo seen displayed on a tablet. 
Igor Golovnov | SOPA Images | Lightrocket | Getty Images

Shares of Danaher popped more than 7% on Tuesday after the life sciences company delivered beats across its three main businesses — a sign the long-awaited turnaround in the biotech industry is finally here.

Articles You May Like

Morgan Stanley tops estimates on strong equities and fixed income trading revenue
IRS’ free Direct File program expands to 25 states — but still faces Republican scrutiny
Netflix to hike prices on standard, ad-supported streaming plans
2 AI Stocks Under $5
Cartier owner Richemont sales rise 10% in December quarter despite ongoing China weakness